These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 24621016

  • 1. Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients.
    Marcelin JR, Wilson JW, Razonable RR, Mayo Clinic Hematology/Oncology and Transplant Infectious Diseases Services.
    Transpl Infect Dis; 2014 Apr; 16(2):242-50. PubMed ID: 24621016
    [Abstract] [Full Text] [Related]

  • 2. Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients.
    Hynicka LM, Ensor CR.
    Ann Pharmacother; 2012 Apr; 46(4):558-66. PubMed ID: 22395247
    [Abstract] [Full Text] [Related]

  • 3. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramilo O.
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [Abstract] [Full Text] [Related]

  • 4. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
    Liu V, Dhillon GS, Weill D.
    Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
    [Abstract] [Full Text] [Related]

  • 5. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.
    Beaird OE, Freifeld A, Ison MG, Lawrence SJ, Theodoropoulos N, Clark NM, Razonable RR, Alangaden G, Miller R, Smith J, Young JA, Hawkinson D, Pursell K, Kaul DR.
    Transpl Infect Dis; 2016 Apr; 18(2):210-5. PubMed ID: 26923867
    [Abstract] [Full Text] [Related]

  • 6. Effective use of oral ribavirin for respiratory syncytial viral infections in allogeneic haematopoietic stem cell transplant recipients.
    Gorcea CM, Tholouli E, Turner A, Saif M, Davies E, Battersby E, Dignan FL.
    J Hosp Infect; 2017 Feb; 95(2):214-217. PubMed ID: 28077243
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons.
    Falsey AR, Koval C, DeVincenzo JP, Walsh EE.
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28054734
    [Abstract] [Full Text] [Related]

  • 9. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
    Whimbey E, Champlin RE, Englund JA, Mirza NQ, Piedra PA, Goodrich JM, Przepiorka D, Luna MA, Morice RC, Neumann JL.
    Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study.
    Chakrabarti S, Collingham KE, Holder K, Fegan CD, Osman H, Milligan DW.
    Bone Marrow Transplant; 2001 Oct; 28(8):759-63. PubMed ID: 11781627
    [Abstract] [Full Text] [Related]

  • 14. Respiratory syncytial virus pneumonitis in immunocompromised adults: clinical features and outcome.
    Ebbert JO, Limper AH.
    Respiration; 2005 Oct; 72(3):263-9. PubMed ID: 15942295
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
    Gueller S, Duenzinger U, Wolf T, Ajib S, Mousset S, Berger A, Martin H, Serve H, Bug G.
    Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.
    Khanna N, Widmer AF, Decker M, Steffen I, Halter J, Heim D, Weisser M, Gratwohl A, Fluckiger U, Hirsch HH.
    Clin Infect Dis; 2008 Feb 01; 46(3):402-12. PubMed ID: 18181739
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.